EPCLUSA 150 mg/37.5 mg, coated granules in a sachet 28 sachets
Active ingredients: Sofosbuvir, Velpatasvir
Commercialized according to BDPMDispensing in France: Prescription only
Coated granules28 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EPCLUSA 150 mg/37,5 mg, granulés enrobés en sachet
- Pharmaceutical form
- granulés enrobé
- Route of administration
- orale
- Presentation description
- 28 sachet(s) polytéréphtalate (PET) aluminium polyéthylène
- Marketing authorisation holder
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jan 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60704272CIP73024418CIP133400930244180Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VELPATASVIRgranulés | 37,5 mg · un sachet | SA |
| SOFOSBUVIRgranulés | 150 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.